News

Medlumics raises €14M in a Series E financing co-led by Asabys Partners, VI Partners and CDTI Innvierte, together with existing investors Andera Partners, Caixa Capital Risc and Innogest

• Medlumics develops a unique real-time, photonically guided radiofrequency (RF) irrigated ablation catheter to improve the treatment of Atrial Fibrillation
• The proceeds from the Series E financing will be used to complete the preclinical development and obtain first in human data
•Medlumics strong investor syndicate includes Asabys Partners, VI Partners, Andera Partners, Caixa Capital Risc, Innogest Capital and CDTI Innvierte

| Read more |

Minoryx Therapeutics and Sperogenix Therapeutics enter into an exclusive license agreement to develop and commercialize leriglitazone in mainland China, Hong Kong and Macau

• Sperogenix will receive exclusive rights to develop and commercialize leriglitazone for the treatment of X-linked adrenoleukodystrophy (X-ALD), a rare life-threatening neurological condition
• Minoryx will receive an upfront and milestone payments of up to $78 million, as well as double digit royalties on annual net sales

| Read more |

Caixa Capital Risc takes the award for the best Venture Capital deal of the year for the sale of PlayGiga to Facebook

• Caixa Capital Risc invested nearly 14 million euros in 2019 in 40 startups and made 20 divestments to boost its investment portfolio.
• The CriteriaCaixa venture capital management company currently manages a portfolio of 228 million euros, with 123 companies.

| Read more |

Caixa Capital Risc invests in MealFood Europe, the leading start-up in the industrial insect production sector in Spain

• The CriteriaCaixa venture capital manager and the CDTI Innvierte Economia Sostenible will have 40% of the capital of the Salamanca start-up.
• MealFood Europe is a benchmark company in Europe, specialised in the industrial breeding of insects for animal feed.
• Caixa Capital Risc manages a volume of more than 210 million euros in over 120 innovative companies in Spain and Portugal.

| Read more |

Catalan startup Validated ID participates in a global initiative to develop coronavirus immune passports

Catalan startup Validated ID offers free digital signatures during quarantine and participates in a global initiative to develop coronavirus immune passports.

| Read more |